To relate our findings to the clinical settings, we examined the relationship between the protein expression of KAP1 and SMURF2 in different human normal and breast cancer tissues, using tissue microarrays (TMAs) and IHC analysis. This evidence concerns the gene SMURF2 and breast cancer.